Contribution of mammography to MRI screening in BRCA mutation carriers by BRCA status and age: individual patient data meta-analysis

[1] Antoniou A(2003)Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: a combined analysis of 22 studies Am J Hum Genet 72 1117-1130

[2] Pharoah PD(2007)Meta-analysis of BRCA1 and BRCA2 penetrance J Clin Oncol 25 1329-1333

[3] Narod S(2014)MRI breast screening in high-risk women: cancer detection and survival analysis Breast Cancer Res Treat 145 663-672

[4] Risch HA(2011)The evidence base for breast cancer screening Prev Med 53 100-102

[5] Eyfjord JE(2007)Sensitivity of MRI versus conventional screening in the diagnosis of BRCA-associated breast cancer in a national prospective series Breast (Edinburgh, Scotland) 16 367-374

[6] Hopper JL(2013)Substantial breast cancer risk reduction and potential survival benefit after bilateral mastectomy when compared with surveillance in healthy BRCA1 and BRCA2 mutation carriers: a prospective analysis Ann Oncol 24 2029-2035

[7] Loman N(2012)Differences in natural history between breast cancers in BRCA1 and BRCA2 mutation carriers and effects of MRI screening-MRISC, MARIBS, and Canadian studies combined Cancer Epidemiol Biomarkers Prev 21 1458-1468

[8] Olsson H(2014)Breast screening using 2D-mammography or integrating digital breast tomosynthesis (3D-mammography) for single-reading or double-reading – evidence to guide future screening strategies Eur J Cancer (Oxford, England: 1990) 50 1799-1807

[9] Johannsson O(2010)Exposure to low-dose radiation and the risk of breast cancer among women with a familial or genetic predisposition: a meta-analysis" Eur Radiol 20 2547-2556

[10] Borg A(2010)Prospective multicenter cohort study to refine management recommendations for women at elevated familial risk of breast cancer: the EVA trial J Clin Oncol 28 1450-1457

[1] Antoniou A(2003)Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: a combined analysis of 22 studies Am J Hum Genet 72 1117-1130

[2] Pharoah PD(2007)Meta-analysis of BRCA1 and BRCA2 penetrance J Clin Oncol 25 1329-1333

[3] Narod S(2014)MRI breast screening in high-risk women: cancer detection and survival analysis Breast Cancer Res Treat 145 663-672

[4] Risch HA(2011)The evidence base for breast cancer screening Prev Med 53 100-102

[5] Eyfjord JE(2007)Sensitivity of MRI versus conventional screening in the diagnosis of BRCA-associated breast cancer in a national prospective series Breast (Edinburgh, Scotland) 16 367-374

[6] Hopper JL(2013)Substantial breast cancer risk reduction and potential survival benefit after bilateral mastectomy when compared with surveillance in healthy BRCA1 and BRCA2 mutation carriers: a prospective analysis Ann Oncol 24 2029-2035

[7] Loman N(2012)Differences in natural history between breast cancers in BRCA1 and BRCA2 mutation carriers and effects of MRI screening-MRISC, MARIBS, and Canadian studies combined Cancer Epidemiol Biomarkers Prev 21 1458-1468

[8] Olsson H(2014)Breast screening using 2D-mammography or integrating digital breast tomosynthesis (3D-mammography) for single-reading or double-reading – evidence to guide future screening strategies Eur J Cancer (Oxford, England: 1990) 50 1799-1807

[9] Johannsson O(2010)Exposure to low-dose radiation and the risk of breast cancer among women with a familial or genetic predisposition: a meta-analysis" Eur Radiol 20 2547-2556

[10] Borg A(2010)Prospective multicenter cohort study to refine management recommendations for women at elevated familial risk of breast cancer: the EVA trial J Clin Oncol 28 1450-1457